BGLAP and osteoporosis: The oral administration of 110 mg/day curcumin with 5 mg/day alendronate prevented osteoporosis in 60 postmenopausal women by decreasing the levels of bone-specific alkaline phosphatase and C-terminal cross-linking telopeptides of type I collagen, as well as increasing the levels of osteocalcin and bone mineral density.